Brainsway Deep TMS stimulates the brain region responsible for depression and brings significant improvement to patients, including those with treatment resistant depression, who have tried several types of antidepressants to no avail. Brainsway Deep TMS is a safe and effective outpatient procedure which does not require hospitalization or anesthesia, and entails no memory loss or systemic side effects.

Brainsway’s treatment for depression has been cleared by the U.S. Food and Drug Administration (FDA). The treatment is highly convenient, requiring only 20-minute daily sessions over a period of 4-6 weeks.

About Deep TMS Sessions

In each session, the patient is comfortably seated in a chair, and a cushioned helmet is gently placed over the head. The helmet generates brief magnetic fields, similar to those used in magnetic resonance imaging (MRI). These magnetic fields briefly stimulate the targeted brain area and improve depressive symptoms. Immediately after each session, the patient can return home independently, and resume his/her routine.

Clinically Proven as Effective and Safe for Patients
Deep TMS treatment was tested in a large-scale multi-center study for treating major depressive disorder patients who were taking antidepressants with no improvement. In this study, which included 230 patients, Deep TMS was shown to be effective for these patients. After this study, the FDA cleared Brainsway Deep TMS for the treatment of depression patients who did not improve from any number of previous medication treatments.

In an 18-week study5, following 4 weeks of Brainsway’s depression treatment, the patients’ depressive symptoms were reduced and then were maintained throughout the study. The results show that Deep TMS follow-up treatment can help keep up an antidepressant effect for 18 weeks, following 4 weeks of acute treatment. Brainsway’s treatment was also studied at McGill University in Canada for treating drug-resistant depression. The study showed that Deep TMS decreases depressive and anxious symptoms in cases of severe, treatment resistant depression. Furthermore, Deep TMS treatment was not associated with serious adverse events.

For more information on Deep TMS visit

Download the Brainsway brochure